Invention Grant
- Patent Title: IAP antagonists
-
Application No.: US14903306Application Date: 2014-07-10
-
Publication No.: US09637518B2Publication Date: 2017-05-02
- Inventor: Kyoung S. Kim , Liping Zhang , Erik M. Stang
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Elliott Korsen
- International Application: PCT/US2014/046075 WO 20140710
- International Announcement: WO2015/006524 WO 20150115
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K5/083 ; C07K14/47 ; C07K14/81 ; A61K45/06 ; A61K38/06
Abstract:
There are disclosed compounds that modulate the activity of inhibitors of apoptosis (IAPs), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders and disorders of dysregulated apoptosis, such as cancer, utilizing the compounds of the invention.
Public/Granted literature
- US20160376307A1 IAP ANTAGONISTS Public/Granted day:2016-12-29
Information query
IPC分类:
